Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer

Aberrant expression of ROS1, ALK or c-MET (RAM) is implicated in carcinogenesis and cancer drug resistance. We retrospectively evaluated the effect of RAM expression on outcomes for advanced biliary tract cancer patients, who were treated with gemcitabine plus oxaliplatin (GEMOX), with or without ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Chiang, Nai-Jung, Hsu, Chiun, Chen, Jen-Shi, Tsou, Hsiao-Hui, Shen, Ying-Ying, Chao, Yee, Chen, Ming-Huang, Yeh, Ta-Sen, Shan, Yan-Shen, Huang, Shiu-Feng, Chen, Li-Tzong
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853728/
https://ncbi.nlm.nih.gov/pubmed/27136744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep25369
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados